Makes vascular devices for peripheral vascular disease treatments.
Jun 2026Revenue $262M/yrExpenses $185M/yr
No trend
Figures by year
Is Lemaitre Vascular profitable?
Yes. In the 12 months to Jun 2026, revenue was $262M and expenses $185M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $250M | $182M | $67.9M |
| Dec 2024 | $220M | $168M | $52.3M |
| Dec 2023 | $193M | $157M | $36.7M |
| Dec 2022 | $162M | $135M | $26.8M |
| Dec 2021 | $154M | $118M | $36.4M |
| Dec 2020 | $129M | $101M | $28.8M |
| Dec 2019 | $117M | $96.0M | $21.2M |
| Dec 2018 | $106M | $77.4M | $28.2M |
| Dec 2017 | $101M | $79.8M | $21.1M |
| Dec 2016 | $89.2M | $72.8M | $16.3M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.